In Vivo Time-Related Evaluation of a Therapeutic Neutralization Monoclonal Antibody against Lethal Enterovirus 71 Infection in a Mouse Model

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Li, Zhiqun ^a   Xu, Longfa ^a   He, Delei ^a   Yang, Lisheng ^a   Liu, Che ^a   Chen, Yixin ^a   Shih, James Wai Kuo ^a   Zhang, Jun ^a   Zhao, Qinjian ^a   Cheng, Tong ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CT11F9; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LETHARGY; MORBIDITY; MORTALITY; MOUSE; MUSCLE NECROSIS; NONHUMAN; PARALYSIS; PROTEIN EXPRESSION; SURVIVAL RATE; VIRUS NEUTRALIZATION; WASTING SYNDROME; ANIMAL; BAGG ALBINO MOUSE; ENTEROVIRUS A; ENTEROVIRUS INFECTIONS; IMMUNOLOGY; KAPLAN MEIER METHOD; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS;

EID: 84939435860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109391     Document Type: Article

References (28)

1. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, et al. (2000) Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31: 678-683.
2. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, et al. (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341: 929-935.
3. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, et al. (2003) Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9: 78-85.
4. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351-2352.
5. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778-790.
6. Chan AC, Carter PJ (2010) Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10: 301-316.
7. Cao RY, Han JF, Jiang T, Tian X, Yu M, et al. (2011) In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors. J Clin Virol 51: 246-249.
8. Lim XF, Jia Q, Khong WX, Yan B, Premanand B, et al. (2012) Characterization of an isotype dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS One 7: e29751.
9. Chang GH, Luo YJ, Wu XY, Si BY, Lin L, et al. (2010) Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virol J 7: 106.
10. Xu L, He D, Li Z, Zheng J, Yang L, et al. (2014) Protection against Lethal Enterovirus 71 Challenge in mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop. Theranostics 4: 498-513.
11. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, et al. (2004) A mouseadapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78: 7916-7924.
12. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, et al. (1998) Fatal enterovirus 71 encephalomyelitis. J Pediatr 133: 795-798.
13. Chen Y, Li C, He D, Cheng T, Ge S, et al. (2013) Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine 31: 425-430.
14. Xu F, Yan Q, Wang H, Niu J, Li L, et al. (2010) Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 5: e11388.
15. Xu F, He D, He S, Wu B, Guan L, et al. (2011) Development of an IgM-capture ELISA for Coxsackievirus A16 infection. J Virol Methods 171: 107-110.
16. Yang L, He D, Tang M, Li Z, Liu C, et al. (2014) Development of an enzymelinked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3. Clin Vaccine Immunol 21: 312-320.
17. Wu KX, Ng MM, Chu JJ (2010) Developments towards antiviral therapies against enterovirus Drug Discov Today 15: 1041-1051.
18. Reading SA, Dimmock NJ (2007) Neutralization of animal virus infectivity by antibody. Arch Virol 152: 1047-1059.
19. Hunt AR, Bowen RA, Frederickson S, Maruyama T, Roehrig JT, et al. (2011) Treatment of mice with human monoclonal antibody 24 h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection. Virology 414: 146-152.
20. Smeraski CA, Siddharthan V, Morrey JD (2011) Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1. Antiviral Res 91: 43-49.
21. He F, Kumar SR, Syed Khader SM, Tan Y, Prabakaran M, et al. (2013) Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Res 100: 207-214.
22. Zheng Q, Xia L, Wu WL, Zheng Z, Huo Y, et al. (2011) Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses. Antimicrob Agents Chemother 55: 1349-1357.
23. Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, et al. (2007) Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol 81: 8996-9003.
24. Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, et al. (2008) Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol 67: 532-542.
25. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, et al. (2002) Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91: 632-635.
26. Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, et al. (2008) Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-Associated brainstem encephalitis. J Infect Dis 198: 1002-1006.
27. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, et al. (2003) Pathogenesis of enterovirus 71 Brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188: 564-570.
28. Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S (2011) Sustained high levels of interleukin-6 Contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol 85: 3067-3076.